DOUGLAS H JONES
- Type
- Physician · Allopathic & Osteopathic Physicians / Allergy & Immunology / Allergy
- Where
- LAYTON, UT
- NPI
- 1346324761
- Received
- $556,734 in 911 records, 2019 to 2025
- As principal investigator
- $876,207 of research payments to others in 59 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 138 | $84,920 |
| 2024 | General payment | 206 | $101,755 |
| 2023 | General payment | 122 | $50,085 |
| 2022 | General payment | 108 | $75,987 |
| 2021 | General payment | 81 | $65,621 |
| 2020 | General payment | 104 | $102,005 |
| 2019 | General payment | 152 | $76,358 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 105 | $240,638 |
| Consulting Fee | 49 | $140,893 |
| Honoraria | 34 | $104,071 |
| Travel and Lodging | 236 | $51,715 |
| Food and Beverage | 484 | $19,334 |
| Education | 3 | $81 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-09 | Pharming Healthcare, Inc. | $119 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $5,310 | Consulting Fee | Cash or cash equivalent | Xolair Biological, Immunology | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $634 | Travel and Lodging | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $333 | Travel and Lodging | Cash or cash equivalent | Xolair Biological, Immunology | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $177 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $137 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-12-06 | Genentech USA, Inc. | $102 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-12-04 | Pharming Healthcare, Inc. | $20 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-03 | Pharming Healthcare, Inc. | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-03 | Pharming Healthcare, Inc. | $125 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-03 | Pharming Healthcare, Inc. | $81 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-03 | Pharming Healthcare, Inc. | $22 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-12-02 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-25 | Ionis Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-20 | CSL Behring | $45 | Travel and Lodging | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-11-20 | CSL Behring | $40 | Travel and Lodging | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-11-20 | CSL Behring | $9 | Food and Beverage | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-11-19 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-18 | CSL Behring | $12 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-11-13 | Ionis Pharmaceuticals, Inc. | $5,560 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-13 | Ionis Pharmaceuticals, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-13 | Ionis Pharmaceuticals, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $916 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $213 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $108 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Pharming Healthcare, Inc. | $29 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $26 | Food and Beverage | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | LEO Pharma Inc. | $21 | Food and Beverage | In-kind items and services | ADBRY Biological, DERMATOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $14 | Travel and Lodging | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $13 | Travel and Lodging | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-12 | Ionis Pharmaceuticals, Inc. | $12 | Travel and Lodging | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-11-07 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-11-05 | Takeda Pharmaceuticals U.S.A., Inc. | $27 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-11-05 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | Rhapsido Drug, Immunology | 2025 | |
| 2025-10-29 | Pharming Healthcare, Inc. | $81 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-10-15 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $8,222 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-10-08 | CSL Behring | $7,909 | Consulting Fee | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $44 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-10-08 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-10-07 | Ionis Pharmaceuticals, Inc. | $2,780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-10-03 | CSL Behring | $1,178 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-10-02 | Pharming Healthcare, Inc. | $23 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-09-30 | Ionis Pharmaceuticals, Inc. | $4,170 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-30 | Takeda Pharmaceuticals U.S.A., Inc. | $42 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-09-24 | Cycle Pharmaceuticals Inc | $16 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-09-20 | Ionis Pharmaceuticals, Inc. | $271 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-20 | Ionis Pharmaceuticals, Inc. | $50 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-20 | Ionis Pharmaceuticals, Inc. | $50 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-20 | Ionis Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-19 | Ionis Pharmaceuticals, Inc. | $354 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-19 | Ionis Pharmaceuticals, Inc. | $271 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-19 | Ionis Pharmaceuticals, Inc. | $118 | Travel and Lodging | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-19 | Ionis Pharmaceuticals, Inc. | $75 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-19 | Ionis Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | DAWNZERA Drug, PULMONOLOGY & IMMUNOLOGY | 2025 | |
| 2025-09-18 | Takeda Pharmaceuticals U.S.A., Inc. | $1,169 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-09-18 | Takeda Pharmaceuticals U.S.A., Inc. | $456 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-09-18 | Takeda Pharmaceuticals U.S.A., Inc. | $149 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-09-18 | Takeda Pharmaceuticals U.S.A., Inc. | $110 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-09-13 | CSL Behring | $826 | Travel and Lodging | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-13 | CSL Behring | $80 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-13 | CSL Behring | $60 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-13 | CSL Behring | $45 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-09-11 | Pharming Healthcare, Inc. | $15 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-09-02 | Cycle Pharmaceuticals Inc | $20 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-09-02 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | 2025 | |
| 2025-08-28 | CSL Behring | $2,503 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-08-21 | CSL Behring | $491 | Travel and Lodging | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-08-21 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-08-06 | Pharming Healthcare, Inc. | $19 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-05 | Cycle Pharmaceuticals Inc | $28 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $6,750 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $297 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $263 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $179 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $117 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $115 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $110 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $100 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $23 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $22 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $18 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $7 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-08-01 | Pharming Healthcare, Inc. | $6 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-07-30 | CSL Behring | $7 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-07-29 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-07-25 | CSL Behring | $5,007 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-07-18 | CSL Behring | $158 | Travel and Lodging | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-07-18 | CSL Behring | $123 | Food and Beverage | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-07-16 | CSL Behring | $883 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Andembry Biological, Hematology | 2025 | |
| 2025-07-16 | CSL Behring | $4 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-07-15 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-07-10 | CSL Behring | $711 | Travel and Lodging | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-07-10 | Pharming Healthcare, Inc. | $28 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-07-10 | CSL Behring | $23 | Food and Beverage | In-kind items and services | Andembry Biological, Hematology | 2025 | |
| 2025-06-14 | BioCryst Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2025 | |
| 2025-05-29 | Pharming Healthcare, Inc. | $82 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-05-19 | Cycle Pharmaceuticals Inc | $24 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-05-14 | Pharming Healthcare, Inc. | $25 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-05-14 | CSL Behring | $6 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2025 | |
| 2025-05-12 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-09 | Pharming Healthcare, Inc. | $1,125 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-05-06 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-28 | Takeda Pharmaceuticals U.S.A., Inc. | $2,860 | Consulting Fee | Cash or cash equivalent | EOHILIA Drug, INTERNAL MEDICINE | 2025 | |
| 2025-04-16 | Cycle Pharmaceuticals Inc | $1,370 | Consulting Fee | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-04-09 | Pharming Healthcare, Inc. | $20 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-04-08 | Pharming Healthcare, Inc. | $3,750 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-04-08 | Pharming Healthcare, Inc. | $63 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-04-08 | Pharming Healthcare, Inc. | $42 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-04-08 | Pharming Healthcare, Inc. | $42 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-04-02 | BioCryst US Sales Co., LLC | $33 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2025 | |
| 2025-03-26 | Pharming Healthcare, Inc. | $11 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-03-25 | Cycle Pharmaceuticals Inc | $6 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-03-19 | Cycle Pharmaceuticals Inc | $26 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-03-13 | Takeda Pharmaceuticals U.S.A., Inc. | $1,966 | Consulting Fee | Cash or cash equivalent | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-03-12 | GlaxoSmithKline, LLC. | $16 | Food and Beverage | In-kind items and services | NUCALA Biological, IMMUNOLOGY | 2025 | |
| 2025-03-10 | CSL Behring | $31 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-03-06 | Pharming Healthcare, Inc. | $3,750 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-03-06 | Pharming Healthcare, Inc. | $122 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-03-05 | Pharming Healthcare, Inc. | $21 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-28 | Pharming Healthcare, Inc. | $46 | Food and Beverage | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-27 | CSL Behring | $86 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2025 | |
| 2025-02-27 | Genentech USA, Inc. | $27 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2025 | |
| 2025-02-25 | GENZYME CORPORATION | $22 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-02-13 | Takeda Pharmaceuticals U.S.A., Inc. | $54 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-02-13 | Takeda Pharmaceuticals U.S.A., Inc. | $17 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-02-12 | Pharming Healthcare, Inc. | $113 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-12 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2025 | |
| 2025-02-11 | Pharming Healthcare, Inc. | $198 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-10 | Regeneron Healthcare Solutions, Inc. | $46 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-06 | Pharming Healthcare, Inc. | $3,750 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-06 | Pharming Healthcare, Inc. | $129 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-06 | Pharming Healthcare, Inc. | $15 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-02-05 | Pharming Healthcare, Inc. | $23 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2025-01-22 | GENZYME CORPORATION | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-01-16 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | HYQVIA Biological, IMMUNOLOGY | 2025 | |
| 2025-01-14 | Cycle Pharmaceuticals Inc | $25 | Food and Beverage | Cash or cash equivalent | Sajazir Drug, Immunology | 2025 | |
| 2025-01-08 | Pharming Healthcare, Inc. | $23 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2025 | |
| 2024-12-19 | Genentech USA, Inc. | $8 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2024 | |
| 2024-12-18 | Blueprint Medicines Corporation | $23 | Food and Beverage | Cash or cash equivalent | AYVAKIT Drug, Oncology / Rare Diseases | 2024 | |
| 2024-12-12 | Genentech USA, Inc. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Xolair Biological, Immunology | 2024 | |
| 2024-12-10 | CSL Behring | $24 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2024 | |
| 2024-12-04 | Pharming Healthcare, Inc. | $26 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-12-04 | GENZYME CORPORATION | $7 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-12-03 | BioCryst US Sales Co., LLC | $33 | Food and Beverage | In-kind items and services | ORLADEYO Drug, Immunology | 2024 | |
| 2024-11-13 | GENZYME CORPORATION | $4 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-11-12 | Pharming Healthcare, Inc. | $16 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-27 | Pharming Healthcare, Inc. | $30 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-26 | Genentech USA, Inc. | $27 | Food and Beverage | In-kind items and services | Xolair Biological, Immunology | 2024 | |
| 2024-10-23 | Amgen Inc. | $24 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Inflammation | 2024 | |
| 2024-10-23 | GENZYME CORPORATION | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-10-18 | Pharming Healthcare, Inc. | $19 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-16 | Pharming Healthcare, Inc. | $10 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-09 | Cycle Pharmaceuticals Inc | $86 | Food and Beverage (4 payments) | In-kind items and services | Sajazir Drug, IMMUNOLOGY | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $43 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-10-09 | Takeda Pharmaceuticals U.S.A., Inc. | $40 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-10-07 | Takeda Pharmaceuticals U.S.A., Inc. | $8,222 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-10-05 | Pharming Healthcare, Inc. | $58 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-04 | Pharming Healthcare, Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-03 | Pharming Healthcare, Inc. | $147 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-10-01 | CSL Behring | $27 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2024 | |
| 2024-10-01 | Pharming Healthcare, Inc. | $24 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-26 | Pharming Healthcare, Inc. | $240 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-24 | Pharming Healthcare, Inc. | $16 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-23 | Pharming Healthcare, Inc. | $13 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-16 | Pharming Healthcare, Inc. | $16 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $3,500 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $371 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $329 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | CSL Behring | $130 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $50 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $50 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-14 | Pharming Healthcare, Inc. | $40 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-13 | Pharming Healthcare, Inc. | $95 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-13 | Pharming Healthcare, Inc. | $36 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-13 | Pharming Healthcare, Inc. | $36 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $444 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $251 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $241 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $239 | Travel and Lodging | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-09-12 | Takeda Pharmaceuticals U.S.A., Inc. | $122 | Food and Beverage | In-kind items and services | TAKHZYRO Biological, GENETIC DISEASE | 2024 | |
| 2024-09-10 | CSL Behring | $25 | Food and Beverage | In-kind items and services | Haegarda Biological, Immunology | 2024 | |
| 2024-09-10 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | GLASSIA Biological, IMMUNOLOGY | 2024 | |
| 2024-09-09 | AstraZeneca Pharmaceuticals LP | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TEZSPIRE Biological, Respiratory | 2024 | |
| 2024-09-05 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2024 | |
| 2024-09-03 | AstraZeneca Pharmaceuticals LP | $192 | Travel and Lodging | In-kind items and services | TEZSPIRE Biological, Respiratory | 2024 | |
| 2024-09-03 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | TEZSPIRE Biological, Respiratory | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $4,500 | Consulting Fee | Cash or cash equivalent | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $1,030 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $406 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $158 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $80 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $80 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $50 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $46 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $41 | Food and Beverage | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $27 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $22 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $21 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 | |
| 2024-08-29 | Pharming Healthcare, Inc. | $21 | Travel and Lodging | In-kind items and services | RUCONEST Biological, BIOLOGIC | 2024 |
The latest 200 records of 911.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $1,600 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $2,000 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $100 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $300 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $1,000 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $1,120 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-10-02 | CSL Behring | Metrodora Institute LLC | $1,500 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-07-14 | CSL Behring | Metrodora Institute LLC | $5,676 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $3,200 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $500 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $800 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $840 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $900 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $3,175 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-06-09 | CSL Behring | Metrodora Institute LLC | $3,969 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-05-27 | CSL Behring | Metrodora Institute LLC | $113,515 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-05-23 | CSL Behring | Metrodora Institute LLC | $25,125 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-05-12 | Amgen Inc. | Metrodora Institute | $1,229 | A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Parti | 2025 |
| 2025-04-30 | CSL Behring | Metrodora Institute LLC | $101,690 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $1,700 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $825 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $55 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $190 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $523 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-29 | CSL Behring | Metrodora Institute LLC | $2,263 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-28 | CSL Behring | Metrodora Institute LLC | $16 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-15 | CSL Behring | Metrodora Institute LLC | $63,852 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-09 | CSL Behring | Metrodora Institute LLC | $12,391 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-07 | CSL Behring | Metrodora Institute LLC | $134,799 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-01 | CSL Behring | Metrodora Institute LLC | $190 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-01 | CSL Behring | Metrodora Institute LLC | $75,676 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-01 | CSL Behring | Metrodora Institute LLC | $523 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-01 | CSL Behring | Metrodora Institute LLC | $3,017 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-04-01 | CSL Behring | Metrodora Institute LLC | $1,700 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-03-17 | CSL Behring | Metrodora Institute LLC | $705 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-03-14 | CSL Behring | Metrodora Institute LLC | $6,714 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-03-05 | CSL Behring | Metrodora Institute LLC | $75,676 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $1,600 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $10,500 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $34,454 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $750 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $500 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $300 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $240 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $9,525 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $2,600 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-21 | CSL Behring | Metrodora Institute LLC | $2,300 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-20 | CSL Behring | Metrodora Institute LLC | $242 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-02-05 | CSL Behring | Metrodora Institute LLC | $75,676 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-01-08 | CSL Behring | Metrodora Institute LLC | $75,676 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-01-08 | CSL Behring | Metrodora Institute LLC | $643 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-01-06 | CSL Behring | Metrodora Institute LLC | $115 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-01-06 | CSL Behring | Metrodora Institute LLC | $1,046 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2025-01-06 | CSL Behring | Metrodora Institute LLC | $1,508 | Double-blind, Randomized, Placebo-controlled Phase 3 Study Evaluating Efficacy and Safety of IgPro20 (Subcutaneous Immun | 2025 |
| 2022-07-05 | Takeda Pharmaceuticals U.S.A., Inc. | TANNER MEMORIAL CLINIC | $1,200 | A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LANADE | 2022 |
| 2021-06-16 | Takeda Pharmaceuticals U.S.A., Inc. | TANNER MEMORIAL CLINIC | $1,000 | A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LANADE | 2021 |
| 2020-12-02 | Takeda Pharmaceuticals U.S.A., Inc. | TANNER MEMORIAL CLINIC | $765 | A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LANADE | 2020 |
| 2020-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | TANNER MEMORIAL CLINIC | $5,000 | A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LANADE | 2020 |
| 2020-09-16 | Takeda Pharmaceuticals U.S.A., Inc. | TANNER MEMORIAL CLINIC | $1,500 | A PHASE 3, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LANADE | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Layton, UT, county Davis County, UT, state Utah; placed by its city name.
| Measure | Place (city or town) Layton, UT | County Davis County, UT | State Utah |
|---|---|---|---|
| Population B01003 | 83,286 | 370,924 | 3,392,331 |
| Population, 2020 census P1 | 81,773 | 362,679 | 3,271,616 |
| Median age B01002 | 32.3 | 32.5 | 32.0 |
| Under 18 B01001 | 29.0% | 30.1% | 27.8% |
| 65 and over B01001 | 10.8% | 11.0% | 11.9% |
| Households B11001 | 27,779 | 115,919 | 1,124,822 |
| Foreign born B05002 | 6.9% | 5.8% | 8.9% |
| Median household income B19013 | $102,480 | $110,884 | $95,166 |
| Median family income B19113 | $121,078 | $123,351 | $109,675 |
| Per capita income B19301 | $42,444 | $42,483 | $40,873 |
| Poverty rate B17001 | 8.1% | 6.4% | 8.5% |
| Unemployment rate B23025 | 2.8% | 2.7% | 3.6% |
| Civilian labor force B23025 | 44,526 | 189,751 | 1,778,106 |
| Mean commute (minutes) B08013 | 22.9 | 22.9 | 22.1 |
| Bachelor's degree or higher B15003 | 36.6% | 39.3% | 37.7% |
| Housing units B25001 | 29,155 | 120,879 | 1,223,468 |
| Owner-occupied B25003 | 72.5% | 77.3% | 70.2% |
| Renters B25003 | 27.5% | 22.7% | 29.8% |
| Median home value B25077 | $477,700 | $505,500 | $489,400 |
| Median gross rent B25064 | $1,538 | $1,621 | $1,496 |
| White, not Hispanic B03002 | 76.5% | 79.9% | 74.7% |
| Black B03002 | 1.2% | 1.1% | 1.1% |
| Hispanic or Latino B03002 | 15.5% | 11.7% | 15.9% |
| Asian B03002 | 1.9% | 1.9% | 2.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.3% | 0.6% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Layton, UT.
Comments